Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex ED90 in Obese Patients
NCT02568345Phase 4Completed
- Sponsor
- Faculty of Medical Sciences of Santa Casa de São Paulo
- Start
- Jan 2013
- Primary completion
- Oct 2013
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Faculty of Medical Sciences of Santa Casa de São Paulo. Started Jan 2013; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02568345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568345.